Prime Minister Narendra Modi on Monday said the two already approved made-in-India Covid-19 vaccines are more cost-effective than any other in the world and have been developed as per the country's needs.

Interacting with chief ministers of all states to discuss the Covid-19 situation and the vaccination roll-out in the country, Modi also said that apart from the two already approved vaccines, four others are in the pipeline.

"Our experts have taken all precautions to provide the countrymen with effective vaccines," he said.

The two approved Covid-19 vaccines in India more cost-effective than other vaccines in the world and have been developed as per our needs and situation, he said.

India is entering a decisive phase of vaccination in the fight against Covid-19, he asserted, pointing that the world's largest vaccination programme will start from January 16.

Public representatives are not part of the three-crore corona warriors and frontline workers to be vaccinated first, Modi said.

In the first phase, the cost of vaccination for these 3 crore people would be borne by the central government, he added.

India's drugs regulator has approved Oxford vaccine Covishield, being manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use in the country.

On Saturday last week, Modi had reviewed the status of COVID-19 and vaccine preparedness across states and union territories at a high-level meeting where.

Prime Minister Narendra Modi announced on Monday that the central government will bear the expenses of vaccinating nearly three crore healthcare and frontline workers in the first round and suggested that public representatives, a reference to politicians, should not be part of this initial exercise.

Interacting with state chief ministers, Modi underscored the enormity of what he described as the world's biggest vaccination exercise, which begins from January 16, saying over 30 crore citizens will get the jabs in the next few months in India against only 2.5 crore people who have received them in over 50 countries in around a month so far.

The two already approved made-in-India Covid-19 vaccines are more cost-effective than any other in the world and have been developed as per the country's needs, he said in his remarks in the meeting called to discuss the Covid-19 situation and the vaccination roll-out.

Besides the two vaccines -- Covishield developed by Oxford and British-Swedish company AstraZeneca and manufactured by Serum Institute of India, and Bharat Biotech's Covaxin, four others are in the pipeline, Modi said, asserting that India's fight against the pandemic will enter a decisive stage with the vaccination roll-out.

More vaccines may be available when the exercise moves into the second round, he added.

The prime minister also sought to dispel concerns expressed by some opposition leaders and experts over the approval given to Covaxin without the availability of efficacy data, asserting that scientists have taken all precautions to provide citizens with effective vaccines.

The prime minister said he has been maintaining from the beginning that the scientific community will have the final word on the issue.

India's drug regulator has given nod to Covishield and Covaxin for the emergency use authorisation.

It is a matter of pride that both the vaccines are 'made in India', he said, adding that it can be imagined how much hardship India would have faced if it had to depend on foreign vaccines.

Noting that the first round of vaccination is meant for healthcare and frontline workers, he said, "This is my personal suggestion and no one should take it otherwise. We public representatives are not part of it."

In some countries, including the US and Israel, leading public figures have taken the jabs while top functionaries in a few others have chosen to follow the standard protocol and wait for their turn.

Talking about the Covid-19 situation in India, Modi said the country is in a much better place than many others in terms of the pandemic's spread, and added that this is a matter of happiness but should not induce carelessness.

The panic visible among the people six-eight months back is no longer there, and the increasing confidence among them in the fight against the pandemic has had a positive impact on economic activities as well, the prime minister said.

Modi also asked states to ensure that rumours do not get spread about the vaccination exercise and suggested involving social and religious groups in helping check any rumour-mongering.

On Saturday last week, Modi had reviewed the status of COVID-19 and vaccine preparedness across states and union territories at a high-level meeting where.

He said many states have given good suggestions in fighting the pandemic and the dialogue and cooperation between the Centre and states have been a "great example" of federalism.

After healthcare and frontline workers totalling about three crores, priority will be given to those above 50 years of age and the under-50 population groups with co-morbidities, together numbering around 27 crore, in the next phase.

According to the Health Ministry guidelines on COVID-19 vaccination, the latest electoral roll for Lok Sabha and Legislative Assembly elections will be used to identify the population aged 50 years or more.

At least seven other vaccines are being developed in India, while some others can be imported from abroad, including the one developed by global pharma giant Pfizer which has already applied for import and sale in India of its vaccine for emergency use authorisation.

India's total active caseload has fallen to 2.25 lakh, which accounts for just 2.13 per cent of the total number of coronavirus cases in the country at over 1.04 crore, according to the latest Health Ministry data. More than 1.5 lakh have died so far.

However, the spread of the virus has lessened in a big way in the country as the daily number of new cases has dropped to about 16,000 from a peak of almost 98,000 in September last year.

However, the overall caseload for India is the second-highest in the world after the US, which has reported more than 2 crore cases so far -- almost double of India's cumulative tally.

In terms of deaths also, the US has recorded the most at nearly 3.7 lakh, followed by over 2 lakh in Brazil and about 1.5 lakh in India.

However, India tops the global charts for recovery with more than 1 crore having recuperated after contracting the deadly virus.

Many countries have launched mass vaccination programmes to protect their people from the deadly virus, which was first detected in China in December 2019 and has killed nearly 20 lakh people globally and infected more than 9 crore people since then.

The vaccination drive in India is starting almost one year after the first case was reported on January 30, 2020 in Kerala, though a wider outbreak began in March after a few people in Delhi and adjoining areas were tested positive after returning from abroad.

In December 2020, the UK became the first country to start vaccination, followed by several other nations, including the US, Belarus, Argentina, Belgium, Canada, Chile, Costa Rica, Croatia, Cyprus, the Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Israel, Italy, Kuwait, Malta, Mexico, Oman, Poland, Qatar, Romania, Russia, Saudi Arabia, Serbia, Slovakia, Spain, Switzerland and the UAE.

But shortly after the vaccination programme began in the UK, the country imposed strict lockdown conditions after a more contagious strain of the virus was found. This also led to British Prime Minister Boris Johnson cancelling his visit to India for being the chief guest for Republic Day parade on January 26.